脑磁图在神经科学中的前沿临床应用

Frontier Clinical Applications of Magnetoencephalography in Neuroscience

摘要:

脑磁图（Magnetoencephalography ,MEG）是一种无创脑功能成像技术，通过记录神经元产生的微弱磁场实现毫秒级的时间分辨率。与脑电图（Electroencephalography ,EEG）相比，MEG对脑沟切向电流更敏感，能更精确稳定地进行源定位。传统超导量子干涉器件系统（Superconducting Quantum Interference Device ,SQUID）系统需液氦冷却且较为笨重，而新型光泵磁力计（Optically Pumped Magnetometer ,OPM）系统可在室温下工作，具有可穿戴性且信号增强数倍，为临床应用提供了更广阔的前景。 在临床应用方面，MEG在癫痫术前评估中能定位EEG未能发现的致痫灶，并通过高频振荡（high-frequency oscillations ,HFOs）等标志物提高切除的精准度 。在脑肿瘤术前，MEG可准确定位运动和语言功能区，避免肿瘤引起的神经血管解偶联（neurovascular uncoupling ,NVU）问题，结合影像导航帮助实现更大范围的安全切除 。MEG还能早期检测阿尔茨海默症患者的脑电频谱变化，作为新疗法疗效评估的生物标志 。在帕金森病中，MEG揭示的病理性β振荡与运动症状严重度相关，并可通过MEG-DBS（Deep Brain Stimulation）同步分析优化刺激靶点和参数 。在孤独症谱系障碍（Autism Spectrum Disorder ,ASD）中，MEG（尤其是OPM）能够有效克服低龄及感觉敏感患者的配合难题，精准捕捉兴奋/抑制（excitation/inhibition ,E/I）失衡及Gamma振荡异常，推动ASD向基于客观神经生理标志物的精准诊疗转变。 随着OPM技术的发展，MEG在定位、手术指导、早期诊断和治疗优化中正发挥着日益关键的作用，持续推动神经疾病的精准诊疗。

Abstract:

Magnetoencephalography (MEG) represents a sophisticated, non-invasive functional neuroimaging modality that resolves neuronal activity with millisecond temporal precision. Unlike Electroencephalography (EEG), MEG detects magnetic fields that permeate the skull and scalp with negligible distortion, offering superior source localization accuracy, particularly for tangential currents originating in cortical sulci. A pivotal evolution in this field is the technological transition from traditional Superconducting Quantum Interference Device (SQUID) systems—which are bulky, stationary, and reliant on cryogenic liquid helium—to next-generation Optically Pumped Magnetometer (OPM) sensors. OPMs operate at room temperature and can be placed directly on the scalp, significantly enhancing signal-to-noise ratios while enabling wearable, motion-tolerant designs that revolutionize pediatric and naturalistic neuroscience. In clinical epileptology, MEG has become indispensable for the presurgical evaluation of drug-resistant epilepsy, particularly in MRI-negative cases. It effectively localizes epileptogenic zones (EZs) often obscured in scalp EEG and guides the strategic implantation of stereoelectroencephalography (SEEG) electrodes. Crucially, MEG is uniquely capable of non-invasively detecting High-Frequency Oscillations (HFOs), a highly specific biomarker for the seizure onset zone, thereby refining resection boundaries and improving postoperative seizure-free outcomes. In neuro-oncology, MEG addresses a critical limitation of functional MRI: Neurovascular Uncoupling (NVU). In patients with high-grade gliomas, tumor-induced vascular dysregulation often compromises the BOLD signal, leading to false-negative activation maps. MEG, by directly measuring neuronal magnetic fields independent of hemodynamics, accurately delineates eloquent motor and language cortices even in areas of compromised vascular reactivity. This precision facilitates "maximal safe resection," a key prognostic factor for extending overall survival while preserving quality of life. Furthermore, MEG provides unique insights into neurodegenerative and neurodevelopmental disorders. In Alzheimer’s Disease (AD), MEG detects synaptic dysfunction manifested as spectral slowing (increased delta/theta power) and functional network fragmentation, which often precede structural atrophy, offering a window for early diagnosis and therapeutic monitoring. In Parkinson’s Disease (PD), MEG characterizes the dynamics of pathological beta bursts within basal ganglia-cortical loops. These neural signatures correlate with motor severity and are increasingly utilized to optimize Deep Brain Stimulation (DBS) targeting and programming, paving the way for adaptive, closed-loop neuromodulation. Finally, regarding Autism Spectrum Disorder (ASD), the silent, open, and motion-tolerant nature of OPM-MEG overcomes the compliance challenges inherent in examining sensory-sensitive and pediatric populations. It enables the precise quantification of rapid neural dynamics, such as Gamma oscillation abnormalities and Excitation/Inhibition (E/I) imbalance, supporting a paradigm shift from subjective behavioral assessment to objective neurophysiological phenotyping. In summary, with the advent of wearable OPM technology, MEG is evolving from a research instrument into a cornerstone of precision neurology, playing a critical role in localization, surgical guidance, and the development of network-based biomarkers.